SYSTEMATIC REVIEW
Published on 29 Sep 2025
CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis
doi 10.3389/fimmu.2025.1611984
- 1,602 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
145
Total downloads
3,914
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.